Pulse Medical Technologies
AMETHYST WOUND HEALING
EC FUNDED RESEARCH AND DEVELOPMENT
The AMETHYST Project
Project Objective
Objective: There are approximately 2 million people who suffer from chronic wounds such as venous leg ulcers in Europe at the present time.
These wounds typically take between 12 and 24 weeks to heal, but 30% take over two years.
AMETHYST stands for:
Ambulatory Magneto-Enhancement of Transdermal High Yield Silver Therapy
The AMETHYST project was born out of an idea generated by Iain Elder of Pulse Medical Technologies Ltd. Coming from a background in producing medical devices for pain relief using Pulsed ElectroMagnetic Field Therapy (PEMF) and through the extensive research the company undertook into PEMF for wound healing, it became apparent that there was a large unmet need to develop a innovative solution to increase the speed of healing for chronic leg ulcers.
An application was submitted to the EC for an FP7 grant and a consortium of companies and organisations was compiled across Europe with specific skill sets and capabilities to enable the research to be undertaken. In addition, the route to market was confirmed to ensure the developments that were being made would have a commercial value and return in the market place. The application was successful and full time research commenced in Swansea University January 2011 with four post doctorates together with their professors and supervisors. Click HERE to go to the dedicated AMETHYST Project website.
Cost of Leg Ulcers in Europe
The cost to the European healthcare services is at least €8 billion a year in treatment. Two thirds of cases are released immediately for treatment in the community, and it is common for 40% of community nurses' time to be taken up by the management, dressing and care of this type of wound.
You are viewing the text version of this site.
To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.
Need help? check the requirements page.
